Therapeutic application of rTMS in neurodegenerative and movement disorders: A review

被引:17
作者
Pateraki, Georgia [1 ]
Anargyros, Konstantinos [1 ]
Aloizou, Athina-Maria [1 ]
Siokas, Vasileios [1 ]
Bakirtzis, Christos [2 ]
Liampas, Ioannis [1 ]
Tsouris, Zisis [1 ]
Ziogka, Pinelopi [1 ]
Sgantzos, Markos [1 ]
Folia, Vasiliki [1 ]
Peristeri, Eleni [1 ]
Dardiotis, Efthimios [1 ]
机构
[1] Univ Thessaly, Univ Hosp Larissa, Dept Neurol, Sch Med, Larisa, Greece
[2] Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Dept Neurol B, Thessaloniki, Greece
关键词
rTMS; Movement disorders; Neurodegenerative disorders; Neurodegeneration; TRANSCRANIAL MAGNETIC STIMULATION; SUPPLEMENTARY MOTOR AREA; THETA-BURST STIMULATION; LEVODOPA-INDUCED DYSKINESIAS; AMYOTROPHIC-LATERAL-SCLEROSIS; FREQUENCY REPETITIVE TMS; 1 HZ RTMS; PARKINSONS-DISEASE; DOUBLE-BLIND; CORTICOSPINAL EXCITABILITY;
D O I
10.1016/j.jelekin.2021.102622
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Transcranial magnetic stimulation (TMS) is a non-invasive form of brain stimulation that makes use of the magnetic field generated when an electric current passes through a magnetic coil placed over the scalp. It can be applied as a single stimulus at a time, in pairs of stimuli, or repetitively in trains of stimuli (repetitive TMS, rTMS). RTMS can induce changes in brain activity, whose after-effects reflect the processes of long-term potentiation and long-term depression, as certain protocols, namely those using low frequencies (<1 Hz) seem to suppress cortical excitability, while those using high frequencies (>1 Hz) seem to enhance it. It is a technique with very few and mostly mild side-effects, whose effects can persist for long time periods, and as such, it has been studied as a potential treatment option in a multitude of neurodegenerative diseases, including those affecting movement. Although rTMS has received approval as a treatment strategy of only a few aspects in movement disorders in the latest guidelines, its further use seems to also be promising in their context. In this review, we gathered the available literature on the therapeutic application of rTMS in movement disorders, namely Parkinson's disease, Amyotrophic Lateral Sclerosis, Huntington's disease, Dystonia, Tic disorders and Essential Tremor.
引用
收藏
页数:18
相关论文
共 162 条
[1]   Phenomenology and classification of dystonia: A consensus update [J].
Albanese, Alberto ;
Bhatia, Kailash ;
Bressman, Susan B. ;
DeLong, Mahlon R. ;
Fahn, Stanley ;
Fung, Victor S. C. ;
Hallett, Mark ;
Jankovic, Joseph ;
Jinnah, Hyder A. ;
Klein, Christine ;
Lang, Anthony E. ;
Mink, Jonathan W. ;
Teller, Jan K. .
MOVEMENT DISORDERS, 2013, 28 (07) :863-873
[2]  
Alemam AI., 2019, J NEUROL RES, V9, P28, DOI [10.14740/jnr512, DOI 10.14740/JNR512]
[3]   PARALLEL ORGANIZATION OF FUNCTIONALLY SEGREGATED CIRCUITS LINKING BASAL GANGLIA AND CORTEX [J].
ALEXANDER, GE ;
DELONG, MR ;
STRICK, PL .
ANNUAL REVIEW OF NEUROSCIENCE, 1986, 9 :357-381
[4]   Relief of primary cervical dystonia symptoms by low frequency transcranial magnetic stimulation of the premotor cortex [J].
Allam, Nasser ;
Brasil-Neto, Joaquim Pereira ;
Brandao, Pedro ;
Weiler, Fernanda ;
de Barros Filho, Jairo ;
Tomaz, Carlos .
ARQUIVOS DE NEURO-PSIQUIATRIA, 2007, 65 (3A) :697-699
[5]   Transcranial magnetic stimulation (TMS) and repetitive TMS in multiple sclerosis [J].
Aloizou, Athina-Maria ;
Pateraki, Georgia ;
Anargyros, Konstantinos ;
Siokas, Vasileios ;
Bakirtzis, Christos ;
Liampas, Ioannis ;
Nousia, Anastasia ;
Nasios, Grigorios ;
Sgantzos, Markos ;
Peristeri, Eleni ;
Dardiotis, Efthimios .
REVIEWS IN THE NEUROSCIENCES, 2021, 32 (07) :723-736
[6]   Repetitive Transcranial Magnetic Stimulation in the Treatment of Alzheimer's Disease and Other Dementias [J].
Aloizou, Athina-Maria ;
Pateraki, Georgia ;
Anargyros, Konstantinos ;
Siokas, Vasileios ;
Bakirtzis, Christos ;
Sgantzos, Markos ;
Messinis, Lambros ;
Nasios, Grigorios ;
Peristeri, Eleni ;
Bogdanos, Dimitrios P. ;
Doskas, Triantafyllos K. ;
Tzeferakos, Georgios ;
Dardiotis, Efthimios .
HEALTHCARE, 2021, 9 (08)
[7]   Transcranial magnetic stimulation and BDNF plasma levels in amyotrophic lateral sclerosis [J].
Angelucci, F ;
Oliviero, A ;
Pilato, F ;
Saturno, E ;
Dileone, M ;
Versace, V ;
Musumeci, G ;
Batocchi, AP ;
Tonali, PA ;
Di Lazzaro, V .
NEUROREPORT, 2004, 15 (04) :717-720
[8]  
[Anonymous], 2001, J Neurol, DOI DOI 10.1007/PL00007826
[9]  
[Anonymous], 2017, BRAIN STIMUL, DOI DOI 10.1016/J.BRS.2017.01.499
[10]  
APA, 1980, Diagnostic and statistical manual of mental disorders